Dr. Tracy Beth Hoeg has been removed from her position as acting director of the Food and Drug Administration's drug program. Her departure follows a series of leadership changes at the agency, including the resignation of FDA Commissioner Marty Makary. Hoeg, who had no prior government management experience, led investigations into the safety of various treatments and vaccines during her tenure. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON This cluster reports on personnel changes within a regulatory agency, not a core AI development or release.
